about
Primary graft dysfunction: lessons learned about the first 72 h after lung transplantationCirculating mitochondrial DNA in patients in the ICU as a marker of mortality: derivation and validationGenetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study.Adherence to sleep apnea therapy and use of lipid-lowering drugs: a study of the healthy-user effectSurvival benefit of lung transplant for cystic fibrosis since lung allocation score implementation.Factors associated with the use of corticosteroids in the initial management of idiopathic pulmonary fibrosisEffect of treatment guidelines on the initial management of idiopathic pulmonary fibrosisViral metagenomics reveal blooms of anelloviruses in the respiratory tract of lung transplant recipientsPatient attitudinal and behavioral factors associated with warfarin non-adherence at outpatient anticoagulation clinics.Factors associated with nonadherence to early goal-directed therapy in the ED.Donor age and early graft failure after lung transplantation: a cohort study.Construct validity of the definition of primary graft dysfunction after lung transplantation.An alternative method of acute lung injury classification for use in observational studies.SNP-set analysis replicates acute lung injury genetic risk factors.A functional synonymous coding variant in the IL1RN gene is associated with survival in septic shock.Shear stress-related mechanosignaling with lung ischemia: lessons from basic research can inform lung transplantation.Cognitive function, mental health, and health-related quality of life after lung transplantation.Can we optimize long-term outcomes in acute respiratory distress syndrome by targeting normoxemia?Heterogeneous phenotypes of acute respiratory distress syndrome after major trauma.Update in lung transplantation 2013.Improved characterization of medically relevant fungi in the human respiratory tract using next-generation sequencing.Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Heart Transplant Report-2009.ANGPT2 genetic variant is associated with trauma-associated acute lung injury and altered plasma angiopoietin-2 isoform ratio.PCSK9 is a critical regulator of the innate immune response and septic shock outcome.Effect of single vs bilateral lung transplantation on plasma surfactant protein D levels in idiopathic pulmonary fibrosisIntegrative genomics identifies 7p11.2 as a novel locus for fever and clinical stress response in humansHospital-based acute care use in survivors of septic shockPrehospital aspirin use and acute respiratory distress syndrome--a case for aspirin in the drinking water?Elevated plasma long pentraxin-3 levels and primary graft dysfunction after lung transplantation for idiopathic pulmonary fibrosis.Primed for Injury: Cigarette Smokers and Acute Respiratory Distress Syndrome.Inflammasome-regulated cytokines are critical mediators of acute lung injuryA panel of lung injury biomarkers enhances the definition of primary graft dysfunction (PGD) after lung transplantationA multibiomarker-based outcome risk stratification model for adult septic shock*.Chest Fat Quantification via CT Based on Standardized Anatomy Space in Adult Lung Transplant Candidates.The ABO Histo-Blood Group and AKI in Critically Ill Patients with Trauma or Sepsis.African American race, obesity, and blood product transfusion are risk factors for acute kidney injury in critically ill trauma patients.Variation in PTX3 is associated with primary graft dysfunction after lung transplantation.Plasma monocyte chemotactic protein-1 levels at 24 hours are a biomarker of primary graft dysfunction after lung transplantation.Objective Estimates Improve Risk Stratification for Primary Graft Dysfunction after Lung Transplantation.Frailty Phenotypes, Disability, and Outcomes in Adult Candidates for Lung Transplantation
P50
Q28084783-AE69EDBC-54C6-414C-9023-74F77016264AQ28660920-88239142-E70C-4947-8238-3B5149A9B7ACQ28943525-E2B67880-8547-461A-8950-B65C442900D4Q30492680-DFAA99AE-020A-4299-AEB9-50E7D78B3A66Q33738670-790FA2CC-FEA4-44CB-880D-7A5965C9D852Q33966279-791065A5-6329-442F-AF5F-2E130DB7B6D3Q34019374-E6C3F049-1879-4907-9D23-B0E856B40A13Q34042462-E7499C6C-CDF4-461F-85D2-7804BDC46A99Q34056113-F2A34584-BBAA-48DF-982B-3DC784A7E209Q34129799-91C494E5-7234-421B-B9D8-BAF4E4E1AAE6Q34147812-35B80969-BC1D-4B31-97FB-E8F31D1B2B6FQ34238666-5078C148-9C4E-4B51-8701-4C5AD9B94D52Q34275307-65A0E69D-1943-47F5-ABE8-DD4D603A48E6Q34320138-19DA8939-6E34-47E7-BB34-2C04D716E61AQ34425911-4CB4509C-099C-46CD-BD3E-D4CBC5673290Q34439910-33117401-9F34-4D86-9309-FBAEB02BBDCBQ34479145-E6793D05-5C1F-4EF7-934F-767D11D35A01Q34479165-2A8E59AC-93EB-4767-A00F-B3C8DA7F6215Q34479261-919608F9-F0A6-48E6-8DC4-1411416D1AA6Q34480293-F10608C6-B908-4267-AE73-490F3802490EQ34515243-3B4EF72E-52B1-49A4-9375-5E686151CD56Q35005285-B20C63CE-58FE-446E-9971-83082384DDE6Q35042517-017F3300-77E3-4C91-AE9C-9D59F1990242Q35125516-E8CA544B-E055-41BB-9CED-AE6E5CFAA429Q35143037-28AE1136-432D-481F-A2CC-982262B7AB7BQ35152830-C14A1187-2ED7-483B-A89B-790524DA17A8Q35177518-B79F75E9-4336-42B8-BD5E-F78D270EF9EBQ35180193-E8EEAE7E-8E42-4DBF-A1EB-949FFEA0BD36Q35507061-6274987F-7F51-4AC0-8865-5E8D65D36E4EQ35962440-B45B2CDE-C5EC-4C02-9CC4-48D8DD517BC1Q36026253-9493DF3E-2C35-42A3-AE35-3C78A34BA742Q36162053-AE09044F-6DFE-4C33-B3D6-2C183DE2403BQ36206033-8C67B45A-920C-4571-9D57-8AE14FF934EBQ36238264-DF8530F5-8598-47C6-A4DA-80C03A15F212Q36250348-8BCC7DC9-8AA9-460E-886F-AD320BFDE54FQ36319587-489D3F9B-CE61-4704-AA5B-81776D86737CQ36345294-D7F81BB7-3E52-4C55-921B-2E116A5337CFQ36405808-6E032588-9341-4EA0-81B9-1913EFAD58B4Q36486043-49737C5E-0AC1-4F60-B701-57D6E43A7049Q36516828-34CF8695-A562-4797-B52D-22936CF0A374
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Jason D Christie
@en
Jason D Christie
@nl
type
label
Jason D Christie
@en
Jason D Christie
@nl
prefLabel
Jason D Christie
@en
Jason D Christie
@nl
P31
P496
0000-0003-0519-218X